1 min readfrom Science News

A popular sunscreen ingredient can finally be sold in the United States

Our take

A significant advancement in solar protection is now approved for U.S. consumers. The FDA has validated bemotrizinol, a long-lasting chemical compound, for use in sunscreens. Empirical data demonstrates bemotrizinol’s efficacy in defending against ultraviolet radiation—a key factor in premature skin aging. This marks a notable addition to the available options for safeguarding against sun damage. For broader context on global environmental monitoring efforts, see our related article, "Ocean monitoring is in trouble: without the US, it’s up to Europe and Asia."
A popular sunscreen ingredient can finally be sold in the United States

The recent FDA approval of bemotrizinol for use in U.S. sunscreens represents a noteworthy shift in the regulatory landscape and a potential advancement in consumer protection. For years, this broad-spectrum UV filter, widely used in Europe and Asia, has been unavailable to American consumers, despite its demonstrated efficacy and stability. The approval highlights a growing recognition of the need to incorporate validated, empirically-supported ingredients into sun protection formulations, particularly as concerns surrounding the environmental impact of existing alternatives continue to mount. This development arrives at a time when global ocean monitoring efforts are facing challenges, as evidenced by Ocean monitoring is in trouble: without the US, it’s up to Europe and Asia to avoid losing sight of the world’s deep-sea ecosystems - The Conversation, emphasizing the importance of rigorous scientific evaluation and international collaboration in addressing complex issues. The delayed approval of bemotrizinol underscores the sometimes-lengthy process of bringing new, validated technologies to market, even when the scientific justification is clear.

The significance of bemotrizinol’s arrival extends beyond simply offering consumers another sunscreen option. Its long-lasting nature and broad-spectrum protection are particularly valuable. Current concerns about the potential ecological consequences of certain UV filters, notably oxybenzone and octinoxate, have led to bans in some regions. While these concerns are validated and deserving of careful consideration, the resulting gap in effective sun protection necessitates the introduction of alternatives that have undergone thorough, peer-reviewed assessment. Bemotrizinol, having been extensively studied and used internationally, offers a degree of certainty regarding its safety and efficacy. The geopolitical context, with recent events involving maritime security in the Strait of Hormuz, as detailed in IRGC Navy Attacks Two Ships Trying To Cross Strait Of Hormuz ‘Illegally’ and Iran Announces ‘Strait Of Hormuz’ Is Closed After U.S Attacks Iranian Sites Near Strategic Waterway, serves as a stark reminder of how interconnected global trade and scientific progress truly are; regulatory decisions impacting even seemingly niche sectors like sunscreen ingredients can have surprisingly broad implications.

The FDA’s decision represents a move toward a more integrated data ecosystem for evaluating chemicals used in consumer products. The longitudinal data generated from bemotrizinol’s use in other countries provided a robust foundation for its approval in the United States, demonstrating the value of international scientific collaboration. This approach aligns with the broader trend toward leveraging real-time data and empirical evidence to inform regulatory decisions. The validation process itself underscores the importance of calibrated methodologies and rigorous testing protocols, essential components of ensuring consumer safety and product efficacy. Moving forward, we anticipate a greater emphasis on incorporating such globally-sourced data into the assessment of new chemicals, accelerating the adoption of safe and effective alternatives. The scrutiny applied to sunscreen ingredients reflects a broader societal expectation for transparency and accountability in the production and regulation of everyday goods.

Ultimately, the approval of bemotrizinol is a positive step toward providing consumers with effective and scientifically sound sun protection options. It also highlights the ongoing need for continuous monitoring and assessment of chemicals used in personal care products, considering both human health and environmental impact. The question now becomes: will this approval catalyze a broader re-evaluation of other chemicals currently used in the United States, prompting a more proactive and data-driven approach to regulatory oversight, and will the U.S. accelerate its participation in global validation efforts to ensure its own ocean health and monitoring capabilities?

The FDA will allow bemotrizinol in sunscreen. The chemical is long-lasting and defends against solar radiation that ages skin.

Read on the original site

Open the publisher's page for the full experience

View original article

Tagged with

#sunscreen#bemotrizinol#FDA#solar radiation#chemical#skin aging#ingredients#United States